[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B. 1.1. 7 and B. 1.351
variants were first identified in the United Kingdom and South Africa, respectively, and have …
variants were first identified in the United Kingdom and South Africa, respectively, and have …
[PDF][PDF] Infection-and vaccine-induced antibody binding and neutralization of the B. 1.351 SARS-CoV-2 variant
VV Edara, C Norwood, K Floyd, L Lai… - Cell host & …, 2021 - cell.com
The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising
concerns about the efficacy of infection-or vaccine-induced antibodies. We compared …
concerns about the efficacy of infection-or vaccine-induced antibodies. We compared …
[HTML][HTML] Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …
B. 1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies
H Zhou, BM Dcosta, MI Samanovic, MJ Mulligan… - MBio, 2021 - Am Soc Microbiol
ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …
[HTML][HTML] SARS-CoV-2 B. 1.1. 7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, R Datir… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is
uncontrolled in many parts of the world, compounded in some areas by higher transmission …
uncontrolled in many parts of the world, compounded in some areas by higher transmission …
A novel and expanding SARS-CoV-2 variant, B. 1.526, identified in New York
Recent months have seen surges of SARS-CoV-2 infection across the globe along with
considerable viral evolution. Extensive mutations in the spike protein of variants B. 1.1. 7 …
considerable viral evolution. Extensive mutations in the spike protein of variants B. 1.1. 7 …
[HTML][HTML] Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng… - Nature, 2021 - nature.com
Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is
compounded in some areas by the higher transmission potential of the B. 1.1. 7 variant …
compounded in some areas by the higher transmission potential of the B. 1.1. 7 variant …
Neutralization of SARS-CoV-2 lineage B. 1.1. 7 pseudovirus by BNT162b2 vaccine–elicited human sera
A Muik, AK Wallisch, B Sänger, KA Swanson, J Mühl… - Science, 2021 - science.org
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage
called B. 1.1. 7 (variant of concern: VOC 202012/01), which is reported to spread more …
called B. 1.1. 7 (variant of concern: VOC 202012/01), which is reported to spread more …
[HTML][HTML] In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rapidly emerging SARS-CoV-2 variants jeopardize antibody-based countermeasures.
Although cell culture experiments have demonstrated a loss of potency of several anti-spike …
Although cell culture experiments have demonstrated a loss of potency of several anti-spike …
Antigenicity and receptor affinity of SARS-CoV-2 BA. 2.86 spike
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant, BA.
2.86, has emerged and spread to numerous countries worldwide, raising alarm because its …
2.86, has emerged and spread to numerous countries worldwide, raising alarm because its …